APPLICATION OF AASM CLINICAL SIGNIFICANCE THRESHOLDS TO ONCE-NIGHTLY SODIUM OXYBATE FOR IMPROVEMENT IN NARCOLEPSY SYMPTOMS

被引：0
|
作者：
Roth, Thomas [1 ]
Thorpy, Michael [2 ]
Kushida, Clete [3 ]
Morse, Anne [4 ]
Dubow, Jordan [5 ]
Gudeman, Jennifer [5 ]
Dauvilliers, Yves [6 ]
机构：
[1] HenryFord Hosp, Detroit, MI USA
[2] MontefioreMed Ctr, Bronx, NY USA
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] Geisinger Commonwealth Sch Med, Scranton, PA USA
[5] Avadel Pharmaceut, Dublin, Ireland
[6] Univ Montpellier, Gui de Chauliac Hosp, Natl Reference Ctr Orphan Dis, CHU Montpellier,INMINSERM, Montpellier, France
来源：
SLEEP | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
0573
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [31] THE PHARMACOKINETIC ADVERSE EVENT RELATIONSHIP FOR FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION
    Seiden, D.
    Grassot, J.
    Monteith, D.
    Dubow, J.
    SLEEP, 2020, 43 : A282 - A283
  • [32] EFFICACY OF FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION, BY NARCOLEPSY SUBTYPE: A POST HOC ANALYSIS FROM THE REST-ON STUDY
    Roy, Asim
    Morse, Anne Marie
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    SLEEP, 2021, 44 : A194 - A194
  • [33] PIVOTAL PHASE 3 STUDY OF FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION, IN PATIENTS WITH NARCOLEPSY: REST-ON PRIMARY RESULTS
    Kushida, Clete
    Shapiro, Colin
    Roth, Thomas
    Thorpy, Michael
    Rosenberg, Russell
    Corser, Bruce
    Ajayi, Akinyemi
    Dubow, Jordan
    Seiden, David
    Dauvilliers, Yves
    SLEEP, 2021, 44 : A193 - A193
  • [34] WEIGHT LOSS WITH FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION FOR THE TREATMENT OF NARCOLEPSY: POST HOC ANALYSIS FROM REST-ON
    Morse, Anne Marie
    Roy, Asim
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    SLEEP, 2021, 44 : A194 - A195
  • [35] The Pharmacokinetic-Adverse Event Relationship For FT218, a Once-Nightly Sodium Oxybate Formulation
    Seiden, David
    Grassot, Julien
    Monteith, David
    Dubow, Jordan
    NEUROLOGY, 2020, 94 (15)
  • [36] LONG-TERM SAFETY OF ONCE-NIGHTLY SODIUM OXYBATE: INTERIM ANALYSIS OF DATA FROM RESTORE
    Stern, Thomas P.
    Roy, Asim
    Shapiro, Colin M.
    Harsh, John
    Ajayi, Akinyemi
    Ibrahim, Sally
    Seiden, David
    Gudeman, Jennifer
    CHEST, 2022, 162 (04) : 2524A - 2525A
  • [37] Long-Term Safety of Once-Nightly Sodium Oxybate: Interim Analysis of Data From RESTORE
    Stern, Thomas
    Roy, Asim
    Shapiro, Colin
    Harsh, John
    Ajayi, Akinyemi
    Ibrahim, Sally
    Seiden, David
    Dubow, Jordan
    Gudeman, Jennifer
    Ibrahim, Sally
    Seiden, David
    Dubow, Jordan
    Gudeman, Jennifer
    NEUROLOGY, 2023, 100 (17)
  • [38] Efficacy of FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), by Narcolepsy Subtype: Post Hoc Analysis from REST-ON
    Roy, Asim
    Morse, Anne Marie
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    ANNALS OF NEUROLOGY, 2021, 90 : S239 - S239
  • [39] Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary
    Dauvilliers, Yves
    Roth, Thomas
    Bogan, Richard
    Thorpy, Michael J.
    Morse, Anne Marie
    Ascencion, Feri
    Gudeman, Jennifer
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (09)
  • [40] Weight Loss with FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), for the Treatment of Narcolepsy: Post Hoc Analysis from REST-ON
    Morse, Anne Marie
    Roy, Asim
    Dubow, Jordan
    Seiden, David
    Bogan, Richard
    ANNALS OF NEUROLOGY, 2021, 90 : S242 - S242
12345